Trial · NCT00048542
Participant flow72
How many started, completed or left each group, period by period.
1 to 20 of 72
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-Blind Phase | STARTED | Double-Blind Adalimumab + MTX | 38 | |
| Double-Blind Phase | STARTED | Double-Blind Placebo + MTX | 37 | |
| Double-Blind Phase | STARTED | Double-Blind Adalimumab | 30 | |
| Double-Blind Phase | STARTED | Double-Blind Placebo | 28 | |
| Double-Blind Phase | STARTED | Open-Label Extension BSA Adalimumab + MTX | 0 | |
| Double-Blind Phase | STARTED | Open-Label Extension BSA Adalimumab | 0 | |
| Double-Blind Phase | STARTED | Open-Label Extension FD Adalimumab + MTX | 0 | |
| Double-Blind Phase | STARTED | Open-Label Extension FD Adalimumab | 0 | |
| Double-Blind Phase | COMPLETED | Double-Blind Adalimumab + MTX | 35 | |
| Double-Blind Phase | COMPLETED | Double-Blind Placebo + MTX | 36 | |
| Double-Blind Phase | COMPLETED | Double-Blind Adalimumab | 29 | |
| Double-Blind Phase | COMPLETED | Double-Blind Placebo | 28 | |
| Double-Blind Phase | COMPLETED | Open-Label Extension BSA Adalimumab + MTX | 0 | |
| Double-Blind Phase | COMPLETED | Open-Label Extension BSA Adalimumab | 0 | |
| Double-Blind Phase | COMPLETED | Open-Label Extension FD Adalimumab + MTX | 0 | |
| Double-Blind Phase | COMPLETED | Open-Label Extension FD Adalimumab | 0 | |
| Double-Blind Phase | NOT COMPLETED | Double-Blind Adalimumab + MTX | 3 | |
| Double-Blind Phase | NOT COMPLETED | Double-Blind Placebo + MTX | 1 | |
| Double-Blind Phase | NOT COMPLETED | Double-Blind Adalimumab | 1 | |
| Double-Blind Phase | NOT COMPLETED | Double-Blind Placebo | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00048542/flow